
ISA 2022: meeting highlights and recent updates in amyloidosis
VJHemOnc Podcast
Impact of Blood Biomarkers and Long-Term Outcomes in Amyloidosis
This chapter explores the impact of blood biomarkers on the outcomes of amyloidosis patients, emphasizing clone-related factors and the potential for deep responses to therapy. It also discusses the role of biomarkers in identifying patients at risk of relapse and questions the role of stem cell transplant in the era of DARA-based treatment.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.